awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53441582-5080F699-D123-4BD8-A966-76EDD920DA1C
Q53441582-5080F699-D123-4BD8-A966-76EDD920DA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53441582-5080F699-D123-4BD8-A966-76EDD920DA1C
Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.
P2860
Q53441582-5080F699-D123-4BD8-A966-76EDD920DA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53441582-5080F699-D123-4BD8-A966-76EDD920DA1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ab43c03473f983a6245fc793fa06cd7bbab323be
P2860
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)